Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

NeuroSense Therapeutics Ltd.  ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, today announced that the ...

Humans and many other animals can innately recognize familiar objects in their surroundings, irrespective of the angle they are observed from, changes in lighting or other shifts in the surrounding ...